Sign In
to Vote &
Create Storyboards.
 
The shift from serologic human leukocyte antigen (HLA) testing to allele-specific molecular testing was a necessary prerequisite to successful unrelated donor transplantation. However, although there is a correlation between allelic mismatch, graft-versus-host disease (GVHD), and mortality, post-transplant patient outcomes remain somewhat unpredictable. In this week's issue of Blood, Pidala and colleagues offer new insights into the prognostic significance of specific HLA class I mismatches and ...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard